Latest filing published 10 Jun 2020 for Orthofix Medical Inc..
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ronald A. Matricaria discloses dealings in 4 companies, chiefly Orthofix Medical Inc., Invitrogen Corp and Volcano Corp. We count 43 filings; the first trade dates from 30 June 2006 and the latest from 8 June 2020.
Every open-market trade on record is a purchase: 21 purchases worth €4.5M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 15 share grants and 4 option exercises. 2020 to date brings 1 purchase and no sales.
Half of the purchases are above €229k and half below. Of 5 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 11 purchases with a full 90-day history, the hit rate stands at 73% and the median 90-day move at +10.6%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 10 June 2020 with a share grant in Orthofix Medical Inc. The clock since the last published purchase (18 March 2020) now reads 2,410 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations